ID   NCC-DDLPS2-C1
AC   CVCL_A5IJ
DR   Wikidata; Q107116529
RX   PubMed=33555519;
WW   https://en.cellline.jp/product/ncc-ddlps2-c1/
CC   Part of: NCC sarcoma cell line panel.
CC   Population: Japanese.
CC   Senescence: It is possible that this cell line is not immortal and has a finite life span (personal communication of Kondo T.).
CC   Doubling time: ~54 hours (PubMed=33555519).
CC   Omics: SNP array analysis.
CC   Derived from site: In situ; Right thigh; UBERON=UBERON_0000376.
ST   Source(s): PubMed=33555519
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 11,14
ST   D16S539: 9
ST   D21S11: 28,30
ST   D5S818: 13,14
ST   D7S820: 12,13
ST   TH01: 9
ST   TPOX: 8,13
ST   vWA: 17,19
DI   NCIt; C3704; Dedifferentiated liposarcoma
DI   ORDO; Orphanet_99970; Dedifferentiated liposarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   82Y
CA   Cancer cell line
DT   Created: 20-05-21; Last updated: 30-01-24; Version: 6
//
RX   PubMed=33555519; DOI=10.1007/s13577-021-00497-0;
RA   Noguchi R., Yoshimatsu Y., Ono T., Sei A., Hirabayashi K., Ozawa I.,
RA   Kikuta K., Kondo T.;
RT   "Establishment and characterization of a novel cell line,
RT   NCC-DDLPS2-C1, derived from a patient with dedifferentiated
RT   liposarcoma.";
RL   Hum. Cell 34:990-997(2021).
//